{"name":"Paul E Schulz","slug":"paul-e-schulz","ticker":"","exchange":"","domain":"","description":"Paul E Schulz is a biotechnology company focused on the development of innovative cell therapies. The company's lead product, adMSC, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPT2FOdi1VWmdiUnBWeU1JSTJkRDZRRUdhZ3lmSXptSXlJWi1ZVnd2dEpLOW1OWWluTVBWTkRvZTlnNmVNakRRNldhajVRc1lfRmlUNkdFOExqRzQwWmV4MnJaendQQ1JRYlpscVJKdE0xSXpJMlUweUZpbm9aLXVBMjFPaXdwcXhvelNhMHNEVk90VlNQd2o3eEJtMW54S3Nmby1vdjdPMjBzZ1RrQkNUWjFR?oc=5","date":"2025-10-05","type":"pipeline","source":"MDLinx","summary":"Could this stem cell breakthrough reshape Alzheimer’s care? - MDLinx","headline":"Could this stem cell breakthrough reshape Alzheimer’s care?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9jUDk2MzBQVzlFVlpsRWxrbnBjZEFQdkJBRFpKRFRPdllpX0VoZEFLYml5MFlaNmliNzhRLVNodXJtblJLemh6Sm11bWQzdXpFbUVTSURSdk1RcUw3VVl2LXAtY1VfcVNa?oc=5","date":"2024-11-08","type":"pipeline","source":"Being Patient","summary":"Flu Season: Here’s What Skipping the Flu Vaccine Does to Your Dementia Risk - Being Patient","headline":"Flu Season: Here’s What Skipping the Flu Vaccine Does to Your Dementia Risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNZnlzLWdoMS1SVV9qVzZ3TWZKNDZIbmhKRlhNZDRiLUpLZ2ZvYV9tc0RTVGJYVTFBc2dNYnZqODdabnVLejBWZUZDbWZIRXl5UXdBcHEwYXUtY2NvYUFrWk1zSDlIemFST2ppYU13Snc0dlEwUDdCdkQwWjQyT0NkalM1ZzY0ZWg2X0RWV1RGYnZtRG9EZ244NDhzWQ?oc=5","date":"2024-06-26","type":"pipeline","source":"Frontiers","summary":"Interactions Between Aging and Alzheimer’s Disease on Structural Brain Networks - Frontiers","headline":"Interactions Between Aging and Alzheimer’s Disease on Structural Brain Networks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5uMnRIN0oxY3ZlZXJlX0xYMkhETnFKWnVFYmNwSFN1ZlF3MjNRVllaNkVzOTBGcDNENlo2U2xQdUpDcmptS3JMMjg2Y3NQWmFVWGg1Z3ZzZV84bnQ5SFFGRVQtLXFzSmdTcWc?oc=5","date":"2023-12-13","type":"pipeline","source":"Neurology® Journals","summary":"Posterior primary progressive prosopagnosia - Neurology® Journals","headline":"Posterior primary progressive prosopagnosia - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPbldaWDRLd1lJUzJsRWRfQjdGTTdPYzAyQ1JGQWxHXzg3WVIyREx6ZDN0dHhPNHFVRHhOdkpGaVhDNzRZNzA2MGZRSlVGX2VmUjZnTmhTZVJsOEtKdUhHYXI5WDBnNi0xQm9JWldVaVVhN2N2QXZHN3lrN20zZ3V3WTl1RGdfTFoya2tPRk9IdWkzRncwTUZGRjNiekVFeVJZZ1BnOFRyVW1QcER0ell6d3o0azZUNENNa0Y2T291cGxwWUhtOHMydG1FTFZWRzJ5?oc=5","date":"2023-11-09","type":"pipeline","source":"respiratory-therapy.com","summary":"Common Vaccines May Shield Against Alzheimer’s Disease - respiratory-therapy.com","headline":"Common Vaccines May Shield Against Alzheimer’s Disease - respiratory","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-06-29","type":"regulatory","source":"Newswise","summary":"UTHealth Houston expert available to discuss anti-Alzheimer's drug Leqembi ahead of FDA decision | Newswise - Newswise","headline":"UTHealth Houston expert available to discuss anti-Alzheimer's drug Leqembi ahead of FDA decision | Newswise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQWswOEI0OGh5U1VwcDB5dmVhXzBvWW1ibEp3UTZXb3Bfd2RMZ2ZocldscGV4ekhrcGJxSEtfTWk2R0ZsRUVtVDVnOWxGUFhwR0tqd2UyQk9LQUtYd3htMmFjZjY1M09ta0NhUEZ2S2JoTWtYM29jVmxfa0s1RU1KU0NqVTQwNWE5MWJMbERiRTUxUDZRb3UzdktNSUpUeGJSeWU0Wm1heVFOMHpV?oc=5","date":"2022-01-14","type":"pipeline","source":"Houston Chronicle","summary":"New ruling clouds future of Alzheimer’s drug Houston doctor had seen promise with - Houston Chronicle","headline":"New ruling clouds future of Alzheimer’s drug Houston doctor had seen promise with","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}